Acalabrutinib
Update Venetoclax in CLL
Obinutuzumab
Zanubrutinib
NCCN Guidelines for Patients
CLL Society
ASH: COVID-19 Resources for Managing Blood Cancers
Leukemia & Lymphoma Society